The Biden administration is aiming for a mid-September rollout for reformulated Pfizer and Moderna COVID-19 booster shots, after both companies promised they would be able to deliver doses by then, according to the New York Times, citing people familiar with the deliberations.
The new versions are expected to perform better against then now-dominant (yet far more mild than Delta) BA.5 Omicron subvariant, though the Times notes that data on the reformulated shots is still preliminary.
To accomplish the rollout, the Department of Health and Human Services made an advance purchase of 105 million doses of Pfizer’s reformulated offering for $3.2 billion, with a possible fall deployment in mind. A similar agreement with Moderna is expected soon.
- The Case Against Trump is a Diversion From the Monetary Collapse and a Defeat in Ukraine
- Rothschilds, Rockefellers, and More Redpills
- Proof of What JADE HELM 15 really is and why they are doing it. This is VERY important you read. Your life may depend on it.
- The Fed Just Broke EVERYTHING!! (This Is Bad)
- James O’Keefe: “Linda Malone, Maryland elections admin, RESIGNS day after @OKeefeMedia expose showing thousands of contributions through individual Annapolis, MD home addresses”
- CDC Posts Airports Warning Signs Today March 31, 2023
- The TRUTH about the bank runs. Regulators are LYING to you!
- This is beyond disturbing!
- “What I did NOT KNOW was that Mr Macron was not vaccinated. I did not know that most of the members of the government were not.”
- Things Are Starting To Get Really Crazy Out There…